Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs
Ophthalmologica · 2024
DOI: 10.1159/000537939 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Ophthalmologica, 2024. Verfasst von Daniele Veritti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine-Ophthalmology, University of Udine, Udine, Italy. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Retinal Hemorrhage, Angiogenesis Inhibitors, Wet Macular Degeneration. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Submacular hemorrhage (SMH) associated with neovascular age-related macular degeneration (nAMD) precipitates rapid visual decline and impacts quality of life. Treatments vary, but combined recombinant tissue plasminogen activator (tPA) and anti-vascular endothelial growth factor (anti-VEGF) therapy has gained prominence as a viable treatment option.
Objectives
This study aimed to evaluate the efficacy of the combination of tPA and anti-VEGF.
Methods
We conducted a systematic review meta-analysis following PRISMA guidelines, focusing on studies examining tPA and anti-VEGF therapy in SMH secondary to nAMD. Outcomes measured were change in best-corrected visual acuity (BCVA) and success rate of SMH displacement. Meta-regression assessed the relative efficacy of intravitreal and subretinal delivery.
Results
Out of 257 initial reports, 22 studies involving 29 patient populations met inclusion criteria. Our analysis showed significant improvement in BCVA and a high rate of successful SMH displacement with combined tPA and anti-VEGF therapy. No significant differences were found between subretinal and intravitreal tPA administration. Furthermore, when evaluating the effects of subretinal versus intravitreal anti-VEGF administration in patients treated with subretinal tPA, the results indicated similar efficacy.
Conclusions
Combined tPA and anti-VEGF therapy is effective in managing SMH in nAMD patients, significantly improving visual acuity and SMH displacement. The location of tPA and anti-VEGF delivery did not significantly impact outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine-Ophthalmology, University of Udine, Udine, Italy.
- Istituto Europeo di Microchirurgia Oculare - IEMO, Udine/Milan, Italy.
- Department of Medicine-Ophthalmology, University of Udine, Udine, Italy, paolo.lanzetta@uniud.it.
- Istituto Europeo di Microchirurgia Oculare - IEMO, Udine/Milan, Italy, paolo.lanzetta@uniud.it.
Zitieren
APA
Veritti, D., Sarao, V., Martinuzzi, D., Menzio, S., & Lanzetta, P. (2024). Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs. Ophthalmologica. https://doi.org/10.1159/000537939
Vancouver
Veritti D, Sarao V, Martinuzzi D, Menzio S, Lanzetta P. Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs. Ophthalmologica. 2024. doi:10.1159/000537939
BibTeX
@article{Veritti2024,
author = {Veritti, Daniele and Sarao, Valentina and Martinuzzi, Deborah and Menzio, Sara and Lanzetta, Paolo},
title = {Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs},
journal = {Ophthalmologica},
year = {2024},
doi = {10.1159/000537939}
}
EUVIMED